ArticleRMD open2024

Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.

Shotaro Kojima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.